{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T12:41:26Z","timestamp":1697978486944},"reference-count":26,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2007,3,2]],"date-time":"2007-03-02T00:00:00Z","timestamp":1172793600000},"content-version":"vor","delay-in-days":7730,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hematological Oncology"],"published-print":{"date-parts":[[1986,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Twenty\u2010three consecutive patients with cutaneous T\u2010cell lymphomas were submitted to staging procedures including lymphangiography, bone marrow biopsy and aspiration, peripheral blood morphological examination, peritoneoscopy with liver and spleen biopsy, and in selected patients lymph node biopsies. Extracutaneous disease (lymph nodes, bone marrow, liver and spleen) was detected in 12 patients. Bone marrow was involved in 25 per cent of the patients at presentation (all patients had lymph node involvement) and in two of nine patients with advanced disease during the follow\u2010up. Peripheral blood was involved in 65 per cent of the patients at presentation (ten patients with advanced disease) and in six of nine patients with advanced disease during the follow\u2010up. In 16 patients with advanced disease (T3\u2010T4 and\/or extracutaneous disease), CVP was given with a 50 per cent objective response rate and four complete remissions of 47+, 12+, 19 and 19 months duration. Median survival of patients with advanced disease was 4 years.<\/jats:p>","DOI":"10.1002\/hon.2900040110","type":"journal-article","created":{"date-parts":[[2007,2,19]],"date-time":"2007-02-19T12:17:32Z","timestamp":1171887452000},"page":"83-90","source":"Crossref","is-referenced-by-count":5,"title":["Staging and treatment with cyclophosphamide, vincristine and prednisone (CVP) in advanced cutaneous t\u2010cell lymphomas"],"prefix":"10.1002","volume":"4","author":[{"given":"Umberto","family":"Tirelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonino","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittorina","family":"Zagonel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachele","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Veronesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enzo","family":"Galligioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Tumolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fulvio","family":"Brema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro G.","family":"Trovo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eligio","family":"Grigoletto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,3,2]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.118.7.461"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-93-2-223"},{"key":"e_1_2_1_4_1","first-page":"725","article-title":"Report of the Committee on Cutaneous T\u2010cell Lymphomas: staging classification","volume":"63","author":"Bunn P. A.","year":"1979","journal-title":"Cancer Treat. Rep."},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.117.9.543"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-197201000-00004"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1159\/000249933"},{"key":"e_1_2_1_8_1","first-page":"66","article-title":"Combination chemotherapy for the treatment of advanced stages of mycosis fungoides","volume":"19","author":"Grozea P. N.","year":"1978","journal-title":"Proc. Am. Assoc. Cancer Res. & ASCO"},{"key":"e_1_2_1_9_1","first-page":"647","article-title":"Combination chemotherapy for mycosis fungoides: a Southwest Oncology Group study","volume":"63","author":"Grozea P. N.","year":"1979","journal-title":"Cancer Treat. Rep."},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1982.tb00332.x"},{"key":"e_1_2_1_11_1","first-page":"691","article-title":"Electron\u2010beam therapy for mycosis fungoides: the Stanford University experience","volume":"63","author":"Hoppe R. T.","year":"1979","journal-title":"Cancer Treat. Rep."},{"key":"e_1_2_1_12_1","first-page":"701","article-title":"Status report of 376 mycosis fungoides patients at 4 years: Mycosis Fungoides Cooperative Group","volume":"63","author":"Lamberg S. I.","year":"1979","journal-title":"Cancer Treat. Rep."},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-197607000-00038"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-83-4-534"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6"},{"key":"e_1_2_1_16_1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2340\/00015555598487","article-title":"Epipodophyllotoxin (VP\u201016\u2010213) in mycosis fungoides: a report from the Scandinavian Mycosis Fungoides Group","volume":"59","author":"Molin L.","year":"1979","journal-title":"Acta Dermatol. Venereol. (Stockh)"},{"key":"e_1_2_1_17_1","doi-asserted-by":"crossref","first-page":"542","DOI":"10.2340\/0001555560542544","article-title":"Combination chemotherapy in the tumor stage of mycosis fungoides with cyclophosphamide, vincristine, VP\u201016, adriamycin and prednisolone (COP, CHOP, CAVOP): A report from the Scandinavian Mycosis Fungoides Study Group","volume":"60","author":"Molin L.","year":"1980","journal-title":"Acta Dermatol. Venereal. (Stockh)"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1977.1"},{"key":"e_1_2_1_19_1","first-page":"1371","article-title":"Combination chemotherapy for advanced cutaneous T\u2010cell lymphomas","volume":"64","author":"Raafat J.","year":"1980","journal-title":"Cancer Treat. Rep."},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197410)34:4<1198::AID-CNCR2820340431>3.0.CO;2-E"},{"key":"e_1_2_1_21_1","first-page":"709","article-title":"Scandinavian mycosis fungoides trial","volume":"63","author":"Thomsen K.","year":"1979","journal-title":"Cancer Treat. Rep."},{"key":"e_1_2_1_22_1","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1177\/030089168106700516","article-title":"VM 26 in advanced mycosis fungoides","volume":"67","author":"Tirelli U.","year":"1981","journal-title":"Tumori"},{"key":"e_1_2_1_23_1","first-page":"167","article-title":"Combination chemotherapy with cyclophosphamide, vincristine and prednisone (CVP) in TNM\u2010classified stage IV mycosis fungoides","volume":"66","author":"Tirelli U.","year":"1982","journal-title":"Cancer Treat. Rep."},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197406)33:6<1589::AID-CNCR2820330618>3.0.CO;2-Y"},{"key":"e_1_2_1_25_1","first-page":"681","article-title":"A 10\u2010year experience with topical mechlorethamine for mycosis fungoides: comparison with patients treated by total\u2010skin electron\u2010beam radiation therapy","volume":"63","author":"Vonderheid E. C.","year":"1979","journal-title":"Cancer Treat. Rep."},{"key":"e_1_2_1_26_1","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1182\/blood.V62.2.464.464","article-title":"The immunologic and clinico\u2010pathologic heterogeneity of cutaneous lymphomas other than mycosis fungoides","volume":"62","author":"Wood G. S.","year":"1983","journal-title":"Blood"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.1978.tb00934.x"}],"container-title":["Hematological Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhon.2900040110","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hon.2900040110","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T10:23:59Z","timestamp":1697883839000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hon.2900040110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1986,1]]}},"alternative-id":["10.1002\/hon.2900040110"],"URL":"https:\/\/doi.org\/10.1002\/hon.2900040110","archive":["Portico"],"relation":{},"ISSN":["0278-0232","1099-1069"],"issn-type":[{"value":"0278-0232","type":"print"},{"value":"1099-1069","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986,1]]}}}